Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lantern Pharma Inc.

Clinical trials sponsored by Lantern Pharma Inc., explained in plain language.

Lantern Pharma Inc. LTRN NASDAQ

AI-driven oncology drug development company.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1

New drug LP-184 tested on tough cancers: hope for Late-Stage patients

Disease control Ongoing

This study tests a new drug called LP-184 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors or slow their growth. About 64 participants will receive the drug as an…

Phase: PHASE1, PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC